Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.cscpl.com | |
Market Cap | 1,042.14 Cr. | |
Enterprise Value(EV) | 855.41 Cr. | 2022-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 17.13 | Trailing Twelve Months Ending 2022-03 |
Price-Earning Ratio (PE) | 16.61 | Trailing Twelve Months Ending 2022-03 |
Industry PE | 28.79 | Trailing Twelve Months Ending 2022-03 |
Book Value / Share | 113.89 | Trailing Twelve Months Ending 2022-03 |
Price to Book Value | 2.50 | Calculated using Price: 284.50 |
Dividend Yield | 0.00 | Period Ending 2021-03 |
No. of Shares Subscribed | 3.66 Cr. | 36,630,701 Shares |
FaceValue | 10 | |
Company Profile | ||
The company is a manufacturer of specialised chemicals, such as HMDS and CMIC which are predominantly used in the pharmaceuticals industry (the Pharmaceutical Chemicals), and inorganic bromides, namely Calcium Bromide, Zinc Bromide and Sodium Bromide, which are predominantly used as completion fluids in the oilfields industry. The company supply its products to domestic customers and also export its products to countries including United States of America , Italy, South Korea, Germany, People's Republic of China, Japan, United Arab Emirates, Serbia, Russia, Spain, Thailand and Malaysia. |
1 Day |
|
+1.12% |
1 Week |
|
+5.89% |
1 Month |
|
-0.75% |
3 Month |
|
-4.02% |
6 Month |
|
-21.09% |
1 Year |
|
-37.81% |
2 Year |
|
|
5 Year |
|
|
10 Year |
|
5 years | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | |
Return on Equity (%) | 10.44 | 65.40 | 57.14 | 40.14 | 22.56 | |
Return on Capital Employed (%) | 13.60 | 74.02 | 64.99 | 43.37 | 29.01 | |
Return on Assets (%) | 4.51 | 33.03 | 31.87 | 24.50 | 17.92 |
Particulars | 6 years | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03* Rs. Cr. |
Shh. Funds | 27 | 54 | 97 | 146 | 354 | 417 | |
Non Curr. Liab. | 4 | 5 | 5 | 18 | 5 | 3 | |
Curr. Liab. | 32 | 39 | 71 | 62 | 45 | 78 | |
Minority Int. | |||||||
Equity & Liab. | 63 | 97 | 173 | 226 | 404 | 498 | |
Non Curr. Assets | 26 | 32 | 42 | 53 | 119 | 122 | |
Curr. Assets | 37 | 65 | 131 | 173 | 285 | 376 | |
Misc. Exp. not W/O | |||||||
Total Assets | 63 | 97 | 173 | 226 | 404 | 498 |
Particulars | 6 years | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. TTM |
Net Sales | 90 | 158 | 303 | 262 | 243 | 257 | |
Other Income | 0 | 0 | 2 | 4 | 5 | 9 | |
Total Income | 90 | 158 | 305 | 266 | 248 | 266 | |
Total Expenditure | -81 | -113 | -237 | -192 | -162 | -176 | |
PBIDT | 9 | 46 | 68 | 74 | 86 | 91 | |
Interest | -2 | -3 | -4 | -5 | -4 | -1 | |
Depreciation | -2 | -2 | -3 | -5 | -6 | -6 | |
Taxation | -2 | -14 | -18 | -16 | -20 | -21 | |
Exceptional Items | |||||||
PAT | 3 | 26 | 43 | 49 | 56 | 63 | |
Adjusted EPS | 4 | 33 | 14 | 15 | 15 | 17 |
Particulars | 5 years | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. |
Cash Fr. Operatn. | 2 | 14 | 11 | 12 | 65 | |
Cash Fr. Inv. | -8 | -7 | -24 | -16 | -152 | |
Cash Fr. Finan. | 5 | -6 | 12 | 4 | 111 | |
Net Change | 0 | 1 | 0 | 0 | 23 | |
Cash & Cash Eqvt | 1 | 1 | 1 | 1 | 24 |
Fri, 24 Jun 2022
Closure of Trading Window The "Trading Window" for dealing in securities of the Company shall remain closed for all the "Designated Persons and their immediate relatives" covered under the Code of Conduct from 1st July 2022 till 48 hours after the announcement of Unaudited Financial Results of the Company for the quarter ending June 30th 2022. |
Thu, 23 Jun 2022
Board Meeting Intimation for Notice Is Hereby Given Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 That A Meeting Of The Board Of Directors Of The Company Will Be Held On Tuesday June 28 2022. Chemcon Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/06/2022 inter alia to consider and approve the following matters.1. The Directors Report along with its Annexures for the Financial Year ended March 31 2022.2. The Notice of the 33rd Annual General Meeting of the Company and matters related thereto. |
Thu, 23 Jun 2022
Announcement under Regulation 30 (LODR)-Credit Rating Pursuant to Regulation 30 read with PART A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform that CRISIL has given Rating on the bank facilities of the Company. |
Mon, 27 Jun 2022 |
|
|
|
|
|